Reply To: Feedback Forum
Hello all! Here is a recording (done on my phone) for any and all feedback, a medical commercial. Let me know if my voice sounds authentic for this type of read. Thank you!
We are the thrivers. Women with metastatic breast cancer. Standing in the struggle. Hustling through the hurt. Asking for science, not sorries. Our time… for more time… has come. Living longer is possible and proven in women taking KISQALI plus Fulvestrant or a non-steroidal aroma taste inhibitor. KISQALI can cause lung problems or an abnormal heartbeat which can lead to death. It can also cause serious skin reactions, liver problems, and low white blood cell counts that may result in severe infections. KISQALI is not approved for use with Tomoxafin.
It’s our time…to continue to shine because we are the thrivers. Ask your doctor about KISQALI, the only treatment in its class proven to help women live longer in two clinical trials.